These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2930627)

  • 1. Structural and biochemical comparison of the anti-mitotic agents colchicine, combretastatin A4 and amphethinile.
    McGown AT; Fox BW
    Anticancer Drug Des; 1989 Mar; 3(4):249-54. PubMed ID: 2930627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ; Sriram M; Strecker TE; Tidmore JK; Jelinek CJ; Kumar GD; Hadimani MB; Pettit GR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5146-9. PubMed ID: 18710804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin.
    Lin CM; Ho HH; Pettit GR; Hamel E
    Biochemistry; 1989 Aug; 28(17):6984-91. PubMed ID: 2819042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimitotic and antitubulin activity of the tumor inhibitor steganacin.
    Wang RW; Rebhum LI; Kupchan SM
    Cancer Res; 1977 Sep; 37(9):3071-9. PubMed ID: 560248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the novel agent amphethinile with tubulin.
    McGown AT; Fox BW
    Br J Cancer; 1989 Jun; 59(6):865-8. PubMed ID: 2736224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
    Pettit GR; Minardi MD; Rosenberg HJ; Hamel E; Bibby MC; Martin SW; Jung MK; Pettit RK; Cuthbertson TJ; Chapuis JC
    J Nat Prod; 2005 Oct; 68(10):1450-8. PubMed ID: 16252907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin.
    Rappl C; Barbier P; Bourgarel-Rey V; Grégoire C; Gilli R; Carre M; Combes S; Finet JP; Peyrot V
    Biochemistry; 2006 Aug; 45(30):9210-8. PubMed ID: 16866367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimitotic activity of diaryl compounds with structural features resembling combretastatin A-4.
    Aleksandrzak K; McGown AT; Hadfield JA
    Anticancer Drugs; 1998 Jul; 9(6):545-50. PubMed ID: 9877243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin.
    Sackett DL
    Pharmacol Ther; 1993 Aug; 59(2):163-228. PubMed ID: 8278462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents.
    ter Haar E; Rosenkranz HS; Hamel E; Day BW
    Bioorg Med Chem; 1996 Oct; 4(10):1659-71. PubMed ID: 8931935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate.
    Holwell SE; Cooper PA; Thompson MJ; Pettit GR; Lippert LW; Martin SW; Bibby MC
    Anticancer Res; 2002; 22(6C):3933-40. PubMed ID: 12553015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineoplastic agents. 379. Synthesis of phenstatin phosphate.
    Pettit GR; Toki B; Herald DL; Verdier-Pinard P; Boyd MR; Hamel E; Pettit RK
    J Med Chem; 1998 May; 41(10):1688-95. PubMed ID: 9572894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo.
    Galbraith SM; Chaplin DJ; Lee F; Stratford MR; Locke RJ; Vojnovic B; Tozer GM
    Anticancer Res; 2001; 21(1A):93-102. PubMed ID: 11299795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based discovery of a boronic acid bioisostere of combretastatin A-4.
    Kong Y; Grembecka J; Edler MC; Hamel E; Mooberry SL; Sabat M; Rieger J; Brown ML
    Chem Biol; 2005 Sep; 12(9):1007-14. PubMed ID: 16183025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel imidazole-based combretastatin A-4 analogues: evaluation of their in vitro antitumor activity and molecular modeling study of their binding to the colchicine site of tubulin.
    Bellina F; Cauteruccio S; Monti S; Rossi R
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5757-62. PubMed ID: 16950621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combretastatin-like chalcones as inhibitors of microtubule polymerisation. Part 2: Structure-based discovery of alpha-aryl chalcones.
    Ducki S; Mackenzie G; Greedy B; Armitage S; Chabert JF; Bennett E; Nettles J; Snyder JP; Lawrence NJ
    Bioorg Med Chem; 2009 Nov; 17(22):7711-22. PubMed ID: 19837594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-(3,4,5-Trimethoxyphenylselenyl)-1H-indoles and their selenoxides as combretastatin A-4 analogs: microwave-assisted synthesis and biological evaluation.
    Wen Z; Xu J; Wang Z; Qi H; Xu Q; Bai Z; Zhang Q; Bao K; Wu Y; Zhang W
    Eur J Med Chem; 2015 Jan; 90():184-94. PubMed ID: 25461319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of [3H]mebendazole binding to tubulin by structurally diverse microtubule inhibitors which interact at the colchicine binding site.
    Russell GJ; Lacey E
    Biochem Mol Biol Int; 1995 May; 35(6):1153-9. PubMed ID: 7492951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of drugs affecting microtubular assembly on microtubules, phospholipid synthesis and physiological indices (signalling, growth, motility and phagocytosis) in Tetrahymena pyriformis.
    Kovács P; Csaba G
    Cell Biochem Funct; 2006; 24(5):419-29. PubMed ID: 15912561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues.
    Blokhin AV; Yoo HD; Geralds RS; Nagle DG; Gerwick WH; Hamel E
    Mol Pharmacol; 1995 Sep; 48(3):523-31. PubMed ID: 7565634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.